INVESTIGATION OF THE EFFECT OF ANTIMYCOTICS ON THE CANDIDA BIOFILMS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Objective. To evaluate the anti-biofilm and anti-Candida effects of some actual antimycotics (a ketoconazole-polyethylene oxides (K-PEO) composition, nystatin, and fluconazole) against Candida biofilm cells. Subject and methods. The investigation used the following methods: 1) simulation of Candida biofilms in vitro; 2) study of the biofilm antibiotic resistance of fungi in the genus Candida, by evaluating their viability by a method for determining colony-forming units; 3) estimation of the pathogenicity of Candida, by examining hypho clusters with a differential interference contrast method; 4) scanning electron microscopy; 5) laser scanning confocal microscopy. The biofilms were formed from C. albicans, C. glabrata и C. parapsilosis strains. Results. Among the test antimycotic (anti- Candida) drugs, the K-PEO composition that caused 100% cells death in all the examined strains upon 48-hour exposure of Candida biofilms showed the most potent anti-biofilm effect. The composition also demonstrated anti-virulence properties in suppressing hypho clusters in early (24-hour) biofilms. Conclusion. The K-PEO composition may be effectively used to control Candida biofilms.

Full Text

Restricted Access

About the authors

I. V CHEBOTAR

Nizhny Novgorod State Medical Academy, Ministry of Health of Russia

Email: nizarnn@yandex.ru

V. V PARSHIKOV

Nizhny Novgorod State Medical Academy, Ministry of Health of Russia

Email: pv1610@mail.ru

References

  1. Сергеев А.Ю., Сергеев Ю.В. Кандидоз. Природа инфекции, механизмы агрессии и защиты, лабораторная диагностика, клиника и лечение. М.: Триада-Х; 2001. 472 с.
  2. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R. et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am. J. Obstet. Gynecol. 1998; 178: 203-11.
  3. Harriott M.M., Lilly E.A., Rodriguez T.E., Fidel P.L. Jr., Noverr M.C. Candida albicans forms biofilms on the vaginal mucosa. Microbiology. 2010; 156(Pt12): 3635-44.
  4. Романова Ю.М., Гинцбург А.Л. Бактериальная биопленка как естественная форма существования бактерий в окружающей среде и организме хозяина. Журнал микробиологии, эпидемиологии и иммунобиологии. 2011; 3: 99-109.
  5. Бехало В.А., Бондаренко В.М., Сысолятина Е.В., Нагурская Е.В. Иммунобиологические особенности бактериальных клеток медицинских биопленок. Журнал микробиологии, эпидемиологии и иммунобиологии. 2010; 4: 97-105.
  6. Costerton J.W., Stewart P.S., Greenberg E.P. Bacterial biofilms: a common cause of persistent infections. Science. 1999; 284: 1318-22.
  7. Khot P.D., Suci P.A., Miller R.L., Nelson R.D., Tyler B.J. A small subpopulation of blastospores in Candida albicans biofilms exhibit resistance to amphotericin B associated with differential regulation of ergosterol and beta-1,6-glucan pathway genes. Antimicrob. Agents Chemother. 2006; 50(11): 3708-16.
  8. Ramage G., Vande Walle K., Wickes B.L., Lopez-Ribot J.L. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 2001; 45(9):2475-9.
  9. Чеботарь И.В., Маянский А.Н., Кончакова Е.Д., Лазарева А.В., Чистякова В.П. Антибиотикорезистентность биопленочных бактерий. Клиническая микробиология и антимикробная химиотерапия. 2012; 14(1): 51-8.
  10. Чеботарь И.В. Механизмы антибиопленочного иммунитета. Вестник РАМН. 2012; 12: 22-9.
  11. Frank K.L., Reichert E.J., Piper K.E., Patel R. In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antinicrob. Agents Chemother. 2007; 51(3): 888-95.
  12. Moskowitz S.M., Foster J.M., Emerson J., Burns J.L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol. 2004; 42(5): 1915-22.
  13. Sepandj F., Ceri H., Gibb A., Read R., Olson M. Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis. Perit. Dial. Int. 2004; 24(1): 65-7.
  14. Liu H., Kohler J., Fink G.R. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science. 1994; 266:1723-5.
  15. Danby C.S., Boikov D., Rautemaa-Richardson R., Sobel J. Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob. Agents Chemother. 2012; 56(3): 1403-6.
  16. Batrakova E.V., Kabanov A.V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J. Control Release. 2008; 130(2): 98-106.
  17. Савичева А.М., Кисина В.И., Соколовский Е.В., Башмакова М.А., Гриненко Г.В., Смирнова Т.С. и др. Кандидозный вульвовагинит: Методические рекомендации для врачей. СПб.: «Изд-во Н-Л»; 2009. 88

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2013 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies